CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.
April 30th 2025
CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study.
Friday Frontline: Cancer Updates, Research and Education on March 27, 2020
March 27th 2020From patients having to reschedule treatment appointments due to the novel coronavirus (COVID-19) outbreak, to clinical trials being put on hold, here’s everything you need to know about how the COVID-19 pandemic is impacting patients with cancer.
Friday Frontline: Cancer Updates, Research and Education on March 6, 2020
March 6th 2020From “Jeopardy!” host Alex Trebek giving an update on his cancer journey after reaching the one-year survival mark to how the new coronavirus outbreak in China has impacted cancer care, here’s what is making headlines in the cancer space this week.
FDA Approves Lynparza as First-Line Maintenance Treatment for Metastatic Pancreatic Cancer
December 30th 2019The Food and Drug Administration approved the first PARP inhibitor for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic adenocarcinoma.